InnaVirVax is a French privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and cancer therapies.
InnaVirVax is developing product candidates resulting from a beakthrough discovery, made at Inserm, the French Medical research council, the AP-HP, the largest hospital in Europe, and University Pierre et Marie Curie in Paris. Based on a new paradigm (i.e. the understanding of the mechanism responsible for the decline of the CD4+ T lymphocytes (CD4) in HIV-infected patients), the products currently developed by InnaVirVax will allow the prevention and the treatment of AIDS in HIV-infected patients. Moreover, InnaVirVax has an AIDS prognostic test in its R&D portfolio. Lastly, InnaVirVax is developing an innovative cancer biotherapy.
The discovery has identified that a dysregulation of the innate immune system is responsible for the loss of CD4 in HIV-infected patients. The understanding of this dysregulation (resulting in the presence at the surface of the CD4 of a NK cell ligand, making CD4 sensitive to NK-mediated cell lysis) has allowed InnaVirVax to design a therapeutic vaccine for HIV infection that has been successfully tested in non human primates and which has now recieved the authorization to run a first in man study. In addition InnaVirVax is developing an innovative cancer therapy.
Company Details
- Founded
- -
- Address
- Evry, Essonne
- Phone
- 33 1 80 85 60 83
- co****@****rvax.fr
- Industry
- Biotechnology
- Website
- innavirvax.fr
- HQ
- EVRY, Essonne
Innavirvax Questions
Innavirvax's helpline number is 33 1 80 85 60 83
Innavirvax's website is innavirvax.fr
Innavirvax's LinkedIn profile is https://fr.linkedin.com/company/innavirvax
Innavirvax's industry is
Biotechnology
Innavirvax's top competitors are
Apteeus,
3dlyfe,
Deepor,
Algotx,
Groupe Icare Item Girol,
Uavi,
Diota,
Inside Vision,
Innotrope,
Oip Solutions.
Innavirvax's support email address is contact@innavirvax.fr
Innavirvax's categories are Biotechnology
Innavirvax's founding year is 2008
